SAB Biotherapeutics, Inc. (SABS) NASDAQ

Currency In USD

SAB Biotherapeutics, Inc.

Address

777 W 41st St.

Miami Beach, FL 33140

United States of America (the)

Phone

605 679 6980

Website

https://www.sab.bio

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

February 09, 2021

Key Executives

Name	Title	Pay	Year Born
Samuel J. Reich	CEO & Director	846,462	1975
Christoph Bausch	Executive Vice President & Chief Operating Officer	609,000	1971
Lucy To	Executive Vice President & Chief Financial Officer	684,034	1986
Eddie Joe Sullivan	Co-Founder, President & Director	746,500	1967
Alexandra Kropotova	Executive Vice President & Chief Medical Officer	832,249	1973
Carlos N. Carillo	Senior Vice President of Regulatory Affairs	0	N/A
Cristi Barnett	Vice President of Investor Relations & Corporate Communications	0	N/A
Hua Wu	Senior Vice President of Product Development	0	N/A
Angie Parizek	Senior Vice President of Clinical Operations	0	N/A
Catherine DeRose	Vice President of Human Resources	0	N/A

Description

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.